{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT02380859",
      "orgStudyIdInfo": {
        "id": "",
        "type": "",
        "link": ""
      },
      "secondaryIdInfos": [],
      "organization": {
        "fullName": "Dartmouth Hitchcock Medical Center",
        "class": "OTHER"
      },
      "briefTitle": "Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson's disease",
      "officialTitle": "Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson's disease: a double-blind randomized controlled trial",
      "acronym": ""
    },
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "patientRegistry": false,
      "targetDuration": null,
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "interventionModelDescription": "The study had a double-blind randomized controlled design with two parallel groups. The intended allocation ratio was 1:1 (real:sham); however, the final allocation ratio was 1.38:1 due to a deviation from the intended allocation procedure.",
        "primaryPurpose": "TREATMENT",
        "observationalModel": null,
        "timePerspective": null,
        "maskingInfo": {
          "masking": "DOUBLE",
          "maskingDescription": "The participants, and the researchers responsible for participant enrolment and assessing outcomes were all blinded as to which type of treatment each participant underwent. Participants were allocated to undergo real or sham prism adaptation through a sealed envelope-style blind draw. Regardless of treatment, the researcher stated that the goggles distorted vision. There was no difference in the percentage of people in each group who guessed the treatment that they had been assigned to in the post-treatment session.",
          "whoMasked": [
            "PARTICIPANT",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 31,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": null,
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Change in postural control measured by Berg Balance Scale",
          "description": "14-item test assessing static and dynamic balance. Performance on each item rated from 0 (lowest level of function) to 4 (highest level of function) with a total score out of 56.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in postural control measured by Limits of Stability test",
          "description": "Measures ability to displace center of gravity relative to feet without losing balance or taking a step. Outcomes include reaction time, maximum movement velocity, and maximum extension of center of gravity over the feet.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in postural control measured by Sensory Organization Test",
          "description": "Measures postural control under different somatosensory, visual, and vestibular feedback conditions. Provides composite equilibrium score and center of gravity alignment in forward-backward plane.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in postural control measured by Motor Control Test",
          "description": "Assesses ability of automatic motor system to recover following unexpected external disturbance. Provides composite latency value (time in milliseconds between force plate translation and corrective responses).",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Change in gait measured by Timed Up and Go test",
          "description": "Time (in seconds) for patient to stand up from seated position, walk 3 meters, turn around, walk back, and sit down.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in gait measured by Functional Gait Assessment",
          "description": "10-item test assessing dynamic balance and postural stability during gait. Performance scored from 0 (severe impairment) to 3 (normal) for each item with total out of 30.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in gait measured by Walk Across test",
          "description": "Quantifies characteristics of steady state gait as patient walks across force plate. Average step length and speed recorded.",
          "timeFrame": "Baseline (Day 1) and 1 day post-treatment (Day 15)"
        },
        {
          "measure": "Change in freezing of gait measured by New Freezing of Gait Questionnaire",
          "description": "9-item questionnaire evaluating impact and severity of freezing of gait on locomotion and daily activities. Items scored from 0 or 1 to 3 or 4, with total out of 28.",
          "timeFrame": "Baseline (Day 1), 1 day post (Day 15), 1 week post (Week 3), 1 month post (Week 7), and 3 months post (Week 15)"
        },
        {
          "measure": "Change in confidence measured by Falls Efficacy Scale",
          "description": "10-item questionnaire rating confidence in performing daily activities without falling. Responses from 0 (very confident) to 10 (not very confident) with total out of 100.",
          "timeFrame": "Baseline (Day 1), 1 day post (Day 15), 1 week post (Week 3), 1 month post (Week 7), and 3 months post (Week 15)"
        },
        {
          "measure": "Change in balance confidence measured by Activities-specific Balance Confidence Scale",
          "description": "16-item questionnaire rating confidence in not losing balance or becoming unsteady during specific activities. Responses from 0 to 100% in 10% increments. Average calculated.",
          "timeFrame": "Baseline (Day 1), 1 day post (Day 15), 1 week post (Week 3), 1 month post (Week 7), and 3 months post (Week 15)"
        },
        {
          "measure": "Change in health and daily function measured by Parkinson's Disease Questionnaire 39",
          "description": "39-item questionnaire measuring Parkinson's disease-specific health and daily function. Participants rate extent of problems with mobility and self-care from 0 (never) to 4 (always). Percentage calculated for total and subscales.",
          "timeFrame": "Baseline (Day 1), 1 day post (Day 15), 1 week post (Week 3), 1 month post (Week 7), and 3 months post (Week 15)"
        },
        {
          "measure": "Patient-reported change measured by Patient's Global Impressions of Change",
          "description": "Patients rate change in activity limitations, symptoms, emotions, overall quality of life, freezing of gait, walking, and balance on 7-point Likert scale from 1 (no change) to 7 (a great deal better).",
          "timeFrame": "1 day post (Day 15), 1 week post (Week 3), 1 month post (Week 7), and 3 months post (Week 15)"
        }
      ]
    },
    "eligibilityModule": null
  }
}